Magnetic Resonance Imaging (MRI) Segment Bolsters Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Growth
According to our new research study on "Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Forecast to 2031 - Global Analysis - by Techniques, Noninvasive ICP, Device, and End User", the market was valued at US$1.70 billion in 2024 and is projected to reach US$3.91 billion by 2031; it is estimated to register a CAGR of 12.7% during 2025-2031. The noninvasive traumatic brain injury diagnostic equipment market report emphasizes the trends prevalent in the global market and drivers and deterrents affecting its growth.
The surging number of traumatic brain injuries, a shift toward noninvasive technologies, technological advancements, and AI integration contribute to the ever-increasing noninvasive traumatic brain injury diagnostic equipment market size. However, the high equipment cost and maintenance hamper the growth of the market. Further, increasing use of biomarkers and rapid assays will bring new noninvasive traumatic brain injury diagnostic equipment market trends in the coming years.
Technological Advancements and AI Integration Bolster Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Growth
As imaging hardware becomes more precise and data-rich, there is a growing demand for tools that analyze data, reduce human error, shorten diagnosis time, and push diagnostics closer to real-time. AI integration improves imaging speed, resolution, and diagnostic accuracy. Philips and SyntheticMR AB's Smart Quant Neuro 3D system, launched in March 2024, uses AI-powered SmartSpeed reconstruction to acquire images up to three times faster than traditional methods, with up to 65% higher resolution. This enhancement improves image clarity and reduces scan time, which is critical for trauma cases. Beyond imaging, AI is expanding the capabilities of non-imaging diagnostic technologies. Wearable and point-of-care devices are becoming increasingly advanced, enabling continuous monitoring through wearable EEGs, AI-assisted detection of intracranial bleeding in CT scans, and predictive modeling of TBI outcomes. The network achieved high accuracy in detecting and classifying different types of intracranial bleeding, such as epidural, subdural, and subarachnoid hemorrhages. This factor is central to the market's rapid growth, especially in noninvasive diagnostic modalities.
The noninvasive traumatic brain injury diagnostic equipment market analysis has been carried out by considering the following segments: techniques, noninvasive ICP, device, and end user, and geography. In terms of techniques, the noninvasive traumatic brain injury diagnostic equipment market is bifurcated into electroencephalography (EEG), brain-computer interface (BCI), eye tracking and near-infrared spectroscopy (NIRS), magnetic resonance imaging (MRI), magnetoencephalography (MEG), transcranial magnetic stimulation (TMS), cerebral metabolic rate of oxygen (CMRO2), intracranial pressure, and others.
The magnetic resonance imaging (MRI) segment held the largest share of the noninvasive traumatic brain injury diagnostic equipment market in 2024.
Based on noninvasive ICP, the noninvasive traumatic brain injury diagnostic equipment market is categorized into transcranial doppler ultrasonography (TCD), tympanic membrane displacement (TMD), optic nerve sheath diameter (ONSD), magnetic resonance imaging (MRI), and computer tomography (CT), and fundoscopy and papilledema. The magnetic resonance imaging (MRI), and computer tomography (CT) segment accounted for the largest share of the noninvasive traumatic brain injury diagnostic equipment market in 2024. The global noninvasive traumatic brain injury diagnostic equipment market, by device, is segmented into imaging devices and monitoring devices. The imaging devices segment held the largest share in 2024. Imaging equipment, such as magnetic resonance imaging (MRI) and computed tomography (CT), represents the foundation of the noninvasive traumatic brain injury (TBI) diagnostic market. In acute TBI, CT scans are primarily used as imaging tools because they are quick and effective in picking up severe structural injuries like intracranial bleeding and skull fractures. Moreover, these fundamental technologies are being improved for better performance, and new modalities are being introduced. The implementation of AI in image analysis, among ongoing innovations, is one of the factors contributing to the solidification of imaging devices as a key element in the TBI diagnostic market.
By end user, the global noninvasive traumatic brain injury diagnostic equipment market is segmented into hospitals, clinics, diagnostic centers, and others. The hospitals and clinics segment held the largest share of the market in 2024. The hospitals and clinics responsible for the majority of purchases of imaging and monitoring devices. Hospitals and clinics are preferred end-users for several reasons: they typically have more comprehensive infrastructure, skilled staff, and the financial capacity to procure and maintain advanced diagnostic tools.
Noninvasive Traumatic Brain Injury Diagnostic Equipment Market Share, by End User, 2024 (%)
Source: The Insight Partners Analysis
The geographic scope of the noninvasive traumatic brain injury diagnostic equipment market report includes assessing the market performance in North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. North America is expected to dominate the market in 2024. The noninvasive traumatic brain injury diagnostic equipment market in North America is segmented into the US, Canada, and Mexico. The growth of the US noninvasive traumatic brain injury diagnostic equipment market is attributed to a series of positive technological developments. A report published at the National Library of Medicine (2025) estimates that about 1.7 million people suffer from mild traumatic brain injury (mTBI) every year, the leading causes being falls, motor vehicle crashes, and assaults. This high prevalence underscores the need for user-friendly diagnostic tools.
BrainScope Company, Inc.-based EEG (electroencephalography)-like platforms employ intricate algorithms that enable doctors to evaluate functional and structural brain injuries, providing a fast and noninvasive alternative to traditional methods. Furthermore, near-infrared spectroscopy (NIRS) and transcranial Doppler ultrasound have become popular for their ability to measure brain oxygenation and blood flow without the need for any invasive procedures. The use of AI and ML in diagnostic tools has resulted in improved accuracy and efficiency in TBI detection.
The rise of the US noninvasive TBI diagnostic equipment market is attributed to the advanced healthcare infrastructure, the high prevalence of TBI, and a commitment to research and development in the region. Moreover, the deployment of cutting-edge technologies, supported by government incentives, positions the US favorably to upgrade TBI diagnostics continually.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com